Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

441 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG).
Preusser M, Silvani A, Le Rhun E, Soffietti R, Lombardi G, Sepulveda JM, Brandal P, Brazil L, Bonneville-Levard A, Lorgis V, Vauleon E, Bromberg J, Erridge S, Cameron A, Lefranc F, Clement PM, Dumont S, Sanson M, Bronnimann C, Balaná C, Thon N, Lewis J, Mair MJ, Sievers P, Furtner J, Pichler J, Bruna J, Ducray F, Reijneveld JC, Mawrin C, Bendszus M, Marosi C, Golfinopoulos V, Coens C, Gorlia T, Weller M, Sahm F, Wick W. Preusser M, et al. Among authors: sanson m. Neuro Oncol. 2022 May 4;24(5):755-767. doi: 10.1093/neuonc/noab243. Neuro Oncol. 2022. PMID: 34672349 Free PMC article. Clinical Trial.
Leptomeningeal metastases from solid malignancy: a review.
Taillibert S, Laigle-Donadey F, Chodkiewicz C, Sanson M, Hoang-Xuan K, Delattre JY. Taillibert S, et al. Among authors: sanson m. J Neurooncol. 2005 Oct;75(1):85-99. doi: 10.1007/s11060-004-8101-x. J Neurooncol. 2005. PMID: 16215819 Review.
Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma.
Carpentier A, Laigle-Donadey F, Zohar S, Capelle L, Behin A, Tibi A, Martin-Duverneuil N, Sanson M, Lacomblez L, Taillibert S, Puybasset L, Van Effenterre R, Delattre JY, Carpentier AF. Carpentier A, et al. Among authors: sanson m. Neuro Oncol. 2006 Jan;8(1):60-6. doi: 10.1215/S1522851705000475. Neuro Oncol. 2006. PMID: 16443949 Free PMC article. Clinical Trial.
Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial.
van den Bent MJ, Carpentier AF, Brandes AA, Sanson M, Taphoorn MJ, Bernsen HJ, Frenay M, Tijssen CC, Grisold W, Sipos L, Haaxma-Reiche H, Kros JM, van Kouwenhoven MC, Vecht CJ, Allgeier A, Lacombe D, Gorlia T. van den Bent MJ, et al. Among authors: sanson m. J Clin Oncol. 2006 Jun 20;24(18):2715-22. doi: 10.1200/JCO.2005.04.6078. J Clin Oncol. 2006. PMID: 16782911 Clinical Trial.
No association of MDM2 SNP309 with risk of glioblastoma and prognosis.
El Hallani S, Marie Y, Idbaih A, Rodero M, Boisselier B, Laigle-Donadey F, Ducray F, Delattre JY, Sanson M. El Hallani S, et al. Among authors: sanson m. J Neurooncol. 2007 Dec;85(3):241-4. doi: 10.1007/s11060-007-9416-1. Epub 2007 Jun 14. J Neurooncol. 2007. PMID: 17568997
Brain lymphoma: usefulness of the magnetic resonance spectroscopy.
Taillibert S, Guillevin R, Menuel C, Sanson M, Hoang-Xuan K, Chiras J, Duffau H. Taillibert S, et al. Among authors: sanson m. J Neurooncol. 2008 Jan;86(2):225-9. doi: 10.1007/s11060-007-9468-2. Epub 2007 Sep 4. J Neurooncol. 2008. PMID: 17786533
Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group study.
Mauer ME, Taphoorn MJ, Bottomley A, Coens C, Efficace F, Sanson M, Brandes AA, van der Rijt CC, Bernsen HJ, Frénay M, Tijssen CC, Lacombe D, van den Bent MJ; EORTC Brain Cancer Group. Mauer ME, et al. Among authors: sanson m. J Clin Oncol. 2007 Dec 20;25(36):5731-7. doi: 10.1200/JCO.2007.11.1476. J Clin Oncol. 2007. PMID: 18089867 Clinical Trial.
Genetic markers predictive of chemosensitivity and outcome in gliomatosis cerebri.
Kaloshi G, Everhard S, Laigle-Donadey F, Marie Y, Navarro S, Mokhtari K, Idbaih A, Ducray F, Thillet J, Hoang-Xuan K, Delattre JY, Sanson M. Kaloshi G, et al. Among authors: sanson m. Neurology. 2008 Feb 19;70(8):590-5. doi: 10.1212/01.wnl.0000299896.65604.ae. Neurology. 2008. PMID: 18285534 Clinical Trial.
441 results